Harrison, Ark. (August 5, 2024) –North Arkansas Regional Medical Center announced that Dr. Daniel Decker has been designated as a Center of Excellence for GreenLight™ Laser Therapy treatment – a minimally invasive outpatient procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms.
GreenLight Therapy can help provide immediate relief from enlarged prostate symptoms such as frequent urination—especially at night, weak urine flow, urgency and incomplete bladder emptying. In addition, GreenLight Laser Therapy requires no incisions and typically has no overall deleterious impact on sexual function.1 The Center of Excellence designation recognizes Dr. Decker’s high degree of experience with GreenLight Laser Therapy and commitment to delivering effective, long-lasting therapy to men suffering from benign prostatic hyperplasia (BPH).1
BPH is a condition in which a man’s prostate enlarges and squeezes the urethra, causing frustrating symptoms such as frequent or urgent urination, a weak or interrupted urine stream, and the need to get up several times a night to urinate. It affects about 50% of men by age 60, and up to 90% of men by age 85.2
"I am truly honored to receive this recognition for the Center of Excellence for GreenLight Laser Therapy," said Dr. Daniel Decker. "This accolade highlights our clinical dedication, in partnership with NARMC, to delivering cutting-edge surgical treatments that enhance patient outcomes and quality of life."
GreenLight Laser Therapy is a minimally invasive procedure that has revolutionized the treatment of benign prostatic hyperplasia (BPH). By employing this advanced technology, we offer our patients a safer, more effective alternative to traditional surgical methods, leading to faster recovery and fewer complications.
For our patients, this recognition assures them that they are receiving care from a facility that upholds rigorous standards of excellence. It reaffirms our commitment to "Bringing Better to You" at North Arkansas Regional Medical Center.
"I am deeply grateful to my NARMC administrative and clinical staff for their steadfast support and dedication, which have been crucial in achieving this honor," said Dr. Daniel Decker, Urologist.
GreenLight Laser Therapy uses laser energy to vaporize the enlarged tissue, creating an open channel for urine to pass through the urethra. In addition to typically experiencing immediate improvements in urine flow, many patients are pleased to know that GreenLight typically has no overall deleterious impact on sexual function.1 GreenLight Laser therapy is a long-term solution without the need for BPH medication.1
“Dr. Decker is incredibly easy to communicate with and always has a positive attitude. I felt comfortable discussing my health issues with him, which had become quite debilitating. The GreenLight Laser surgery performed by Dr. Decker has turned my life around. From a urological perspective, I feel like I'm back in my 30’s again! I honestly never expected such remarkable results”, shared patient Philip Milam.
GreenLight Therapy is currently being used in many leading urology practices throughout the United States. To date, more than 1 million patients around the world have been successfully treated with GreenLight Therapy.3
About NARMC
NARMC is an innovative, non-profit healthcare system consisting of a central hospital in Harrison, Arkansas and 15 clinics serving the rural communities of North Arkansas. More than 750 NARMC employees work together to provide a comprehensive range of healthcare services. As one of the Top 100 Rural Hospitals in the nation according to the Rural Health Policy Institute, NARMC has earned numerous 5-star ratings from Healthgrades and consistently ranks high in-patient satisfaction in Press Ganey ratings. A three-time recipient of the Arkansas Governor’s Quality Achievement Award, NARMC is committed to Bringing Better to You.
For more information, visit NARMC Physicians Group at www.narmc.com or TreatMyBPH.com.
1. Bachmann A, Tubaro A, Barber N, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015 Feb;193(2):570-8.
2. What is BPH? Urology Care Foundation website. https://www.urologyhealth.org/urologic-conditions/benign-prostatic-hyperplasia-(bph).
3. Data on file with Boston Scientific.